A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody
Clinical trial NCT04866485 · UNKNOWN
Trial details
- NCT number
- NCT04866485
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-14
- Primary completion
- 2023-02-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.